Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1504433Generated: October 30, 2026

Potassium Carbonate → 1-(2,4'-dichloro-5-methoxy-3'-methyl-[1,1'-biphenyl]-4-yl)-2-oxo-N-(pyrimidin-4-yl)-1,2-dihydroquinoline-6-sulfonamide

https://huagongshe.com/reaction/1504433

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPotassium CarbonateHCID 11430—
Reactant(4-Chloro-3-methylphenyl)boronic acidHCID 3786632—
Reactant1-(4-bromo-5-chloro-2-methoxyphenyl)-2-oxo-N-(pyrimidin-4-yl)-1,2-dihydroquinoline-6-sulfonamideHCID 117737154—
CatalystHCID 178418397HCID 178418397—
Product1-(2,4'-dichloro-5-methoxy-3'-methyl-[1,1'-biphenyl]-4-yl)-2-oxo-N-(pyrimidin-4-yl)-1,2-dihydroquinoline-6-sulfonamideHCID 117737008—

Reaction Conditions

Temperature90 °C

Reaction Steps

A vial was charged with 1-(4-bromo-5-chloro-2-methoxyphenyl)-2-oxo-N-(pyrimidin-4-yl)-1,2-dihydroquinoline-6-sulfonamide (0.219 g, 0.419 mmol), (4-chloro-3-methylphenyl)boronic acid (0.147 g, 0.865 mmol), Pd(Ph3P)4 (0.062 g, 0.054 mmol) and potassium carbonate (0.224 g, 1.621 mmol). The vial was flushed with Ar (g), then dioxane (2.027 ml) and water (0.676 ml) were added. The vial was sparged with N2 for 1 min and heated at 90° C. for 2 h. The mixture was partitioned between 1 N HCl (10 mL) and EtOAc (20 mL), the layers were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were dried (Na2SO4) and concentrated for purification by MPLC (Biotage Isolera). The crude residue was taken up in minimal DCM and absorbed directly onto a dry Biotage SNAP pre-packed silica gel column (50 g) and eluted using a gradient of 100% Heptane 100% of 3:1 EtOAc:EtOH blend to afford 1-(2,4′-dichloro-5-methoxy-3′-methyl-[1,1′-biphenyl]-4-yl)-2-oxo-N-(pyrimidin-4-yl)-1,2-dihydroquinoline-6-sulfonamide as a light-yellow foam. The racemic 1-(2,4′-dichloro-5-methoxy-3′-methyl-[1,1′-biphenyl]-4-yl)-2-oxo-N-(pyrimidin-4-yl)-1,2-dihydroquinoline-6-sulfonamide was subjected to chiral separation by SFC using a Chiralpak AD column with 40% isopropanol in CO2 to provide (P)-1-(2,4′-dichloro-5-methoxy-3′-methyl-[1,1′-biphenyl]-4-yl)-2-oxo-N-(pyrimidin-4-yl)-1,2-dihydroquinoline-6-sulfonamide as peak 1 and (M)-1-(2,4′-dichloro-5-methoxy-3′-methyl-[1,1′-biphenyl]-4-yl)-2-oxo-N-(pyrimidin-4-yl)-1,2-dihydroquinoline-6-sulfonamide as peak 2. Data for peak 1: 1H NMR (500 MHz, DMSO-d6) δ 12.46-12.80 (br. s., 1H), 8.61 (br. s., 1H), 8.43 (br. s., 1H), 8.27-8.37 (m, 1H), 8.23 (d, J=9.72 Hz, 1H), 7.94 (d, J=8.82 Hz, 1H), 7.65 (s, 1H), 7.51-7.61 (m, 2H), 7.43 (dd, J=1.63, 8.04 Hz, 1H), 7.31 (s, 1H), 7.02 (br. s., 1H), 6.73-6.88 (m, 2H), 3.72 (s, 3H), 2.43 (s, 3H). m/z (ESI) 567.0 (M+H)+. Data for peak 2: 1H NMR (500 MHz, DMSO-d6) δ 8.61 (br. s., 1H), 8.43 (br. s., 1H), 8.30 (br. s., 1H), 8.23 (d, J=9.72 Hz, 1H), 7.94 (d, J=8.65 Hz, 1H), 7.65 (s, 1H), 7.57 (dd, J=3.29, 4.73 Hz, 2H), 7.39-7.48 (m, 1H), 7.31 (s, 1H), 7.02 (br. s., 1H), 6.75-6.87 (m, 2H), 3.66-3.75 (m, 3H), 2.43 (s, 3H) (sulfonamide NH missing due to exchange with water). m/z (ESI) 567.0 (M+H)+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09212182B2
Source datasetuspto-grants-2015_12
ORD IDord-f28e21cc5f2646138b37f7a647e9fcad
Source noteuspto-grants-2015_12